Story

Devyser Q2 Sales Fall 10.7% on Distributor Inventory Adjustment

ENTHMSVIIDZHZH-TWJAKOHI
Jul 20, 20261 min read
Devyser Q2 Sales Fall 10.7% on Distributor Inventory Adjustment

Summary

Swedish diagnostics firm Devyser reported a 10.7% year-over-year decline in second-quarter net sales, attributing the drop to a temporary inventory reduction by its largest distributor. The company expects the impact to persist through 2026 before normalizing.

Text size
Background

Swedish diagnostics company Devyser announced a 10.7% year-over-year decline in net sales for the second quarter, a downturn it attributed to a significant inventory adjustment by its primary distribution partner.

Quarterly Performance

Devyser reported that the sales decrease was a direct result of its largest distributor reducing its inventory levels. The company anticipates that sales to this key partner will remain lower than usual for the remainder of 2026.

Key financial results for the quarter include:

  • Net Income: SEK 1.60 million
  • Operating Profit: SEK 500,000
  • Adjusted Earnings Per Share (EPS): SEK 0.10
Sample IUX Markets – In-articleAd

Outlook and Strategic Context

Despite the near-term sales headwind, Devyser stated it expects sales volumes to return to normal levels beginning in 2027. The company maintained its positive long-term outlook, citing that fundamental growth drivers and strong underlying demand for its products remain unchanged.

During the quarter, Devyser also advanced its strategic objectives. On April 1, it completed the acquisition of CyberGene AB, a move that expands its footprint in the aneuploidy testing segment. The company also secured a new contract in Italy valued at SEK 8.9 million.

Read next

More on Stocks
Back to latest news

LATEST